FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120239384> ?p ?o ?g. }

• W2120239384 endingPage "1368" @default.
• W2120239384 startingPage "1356" @default.
• W2120239384 abstract "Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) that have poor prognosis and very few identified molecular targets. Strikingly, a high percentage of TNBCs overexpresses the EGF receptor (EGFR), yet EGFR inhibition has yielded little clinical benefit. Over the last decade, advances in EGFR biology have established that EGFR functions in two distinct signaling pathways: (i) classical membrane-bound signaling and (ii) nuclear signaling. Previous studies have demonstrated that nuclear EGFR (nEGFR) can enhance resistance to anti-EGFR therapies and is correlated with poor overall survival in breast cancer. On the basis of these findings, we hypothesized that nEGFR may promote intrinsic resistance to cetuximab in TNBC. To examine this question, a battery of TNBC cell lines and human tumors were screened and found to express nEGFR. Knockdown of EGFR expression demonstrated that TNBC cell lines retained dependency on EGFR for proliferation, yet all cell lines were resistant to cetuximab. Furthermore, Src Family Kinases (SFKs) influenced nEGFR translocation in TNBC cell lines and in vivo tumor models, where inhibition of SFK activity led to potent reductions in nEGFR expression. Inhibition of nEGFR translocation led to a subsequent accumulation of EGFR on the plasma membrane, which greatly enhanced sensitivity of TNBC cells to cetuximab. Collectively, these data suggest that targeting both the nEGFR signaling pathway, through the inhibition of its nuclear transport, and the classical EGFR signaling pathway with cetuximab may be a viable approach for the treatment of patients with TNBC." @default.
• W2120239384 created "2016-06-24" @default.
• W2120239384 creator A5003271971 @default.
• W2120239384 creator A5003826371 @default.
• W2120239384 creator A5006162404 @default.
• W2120239384 creator A5009777686 @default.
• W2120239384 creator A5011388011 @default.
• W2120239384 creator A5023671134 @default.
• W2120239384 creator A5039868720 @default.
• W2120239384 creator A5040571934 @default.
• W2120239384 creator A5071213898 @default.
• W2120239384 creator A5088771820 @default.
• W2120239384 creator A5089257042 @default.
• W2120239384 date "2014-05-01" @default.
• W2120239384 modified "2023-10-11" @default.
• W2120239384 title "Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer" @default.
• W2120239384 cites W1508835219 @default.
• W2120239384 cites W1932563524 @default.
• W2120239384 cites W1964071325 @default.
• W2120239384 cites W1968366677 @default.
• W2120239384 cites W1969175190 @default.
• W2120239384 cites W1979430724 @default.
• W2120239384 cites W1988055795 @default.
• W2120239384 cites W1988106671 @default.
• W2120239384 cites W1988142400 @default.
• W2120239384 cites W1994861590 @default.
• W2120239384 cites W1996275566 @default.
• W2120239384 cites W1996894304 @default.
• W2120239384 cites W1998635509 @default.
• W2120239384 cites W2003405179 @default.
• W2120239384 cites W2024924162 @default.
• W2120239384 cites W2025974334 @default.
• W2120239384 cites W2029935304 @default.
• W2120239384 cites W2042327295 @default.
• W2120239384 cites W2064434163 @default.
• W2120239384 cites W2070522144 @default.
• W2120239384 cites W2072000804 @default.
• W2120239384 cites W2099335989 @default.
• W2120239384 cites W2100766868 @default.
• W2120239384 cites W2101428201 @default.
• W2120239384 cites W2105288740 @default.
• W2120239384 cites W2109399507 @default.
• W2120239384 cites W2110808439 @default.
• W2120239384 cites W2111624138 @default.
• W2120239384 cites W2127902440 @default.
• W2120239384 cites W2134539328 @default.
• W2120239384 cites W2137317814 @default.
• W2120239384 cites W2138095640 @default.
• W2120239384 cites W2140777225 @default.
• W2120239384 cites W2141428376 @default.
• W2120239384 cites W2143905730 @default.
• W2120239384 cites W2145430926 @default.
• W2120239384 cites W2150737519 @default.
• W2120239384 cites W2151837479 @default.
• W2120239384 cites W2154889628 @default.
• W2120239384 cites W2157840751 @default.
• W2120239384 cites W2160557950 @default.
• W2120239384 cites W2170856503 @default.
• W2120239384 cites W2409668309 @default.
• W2120239384 doi "https://doi.org/10.1158/1535-7163.mct-13-1021" @default.
• W2120239384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4013210" @default.
• W2120239384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30936412" @default.
• W2120239384 hasPublicationYear "2014" @default.
• W2120239384 type Work @default.
• W2120239384 sameAs 2120239384 @default.
• W2120239384 citedByCount "49" @default.
• W2120239384 countsByYear W21202393842014 @default.
• W2120239384 countsByYear W21202393842015 @default.
• W2120239384 countsByYear W21202393842016 @default.
• W2120239384 countsByYear W21202393842017 @default.
• W2120239384 countsByYear W21202393842018 @default.
• W2120239384 countsByYear W21202393842019 @default.
• W2120239384 countsByYear W21202393842020 @default.
• W2120239384 countsByYear W21202393842021 @default.
• W2120239384 countsByYear W21202393842022 @default.
• W2120239384 countsByYear W21202393842023 @default.
• W2120239384 crossrefType "journal-article" @default.
• W2120239384 hasAuthorship W2120239384A5003271971 @default.
• W2120239384 hasAuthorship W2120239384A5003826371 @default.
• W2120239384 hasAuthorship W2120239384A5006162404 @default.
• W2120239384 hasAuthorship W2120239384A5009777686 @default.
• W2120239384 hasAuthorship W2120239384A5011388011 @default.
• W2120239384 hasAuthorship W2120239384A5023671134 @default.
• W2120239384 hasAuthorship W2120239384A5039868720 @default.
• W2120239384 hasAuthorship W2120239384A5040571934 @default.
• W2120239384 hasAuthorship W2120239384A5071213898 @default.
• W2120239384 hasAuthorship W2120239384A5088771820 @default.
• W2120239384 hasAuthorship W2120239384A5089257042 @default.
• W2120239384 hasBestOaLocation W21202393841 @default.
• W2120239384 hasConcept C121608353 @default.
• W2120239384 hasConcept C126322002 @default.
• W2120239384 hasConcept C173396325 @default.
• W2120239384 hasConcept C2777506169 @default.
• W2120239384 hasConcept C2779438470 @default.
• W2120239384 hasConcept C2779998722 @default.
• W2120239384 hasConcept C2780110267 @default.
• W2120239384 hasConcept C2781187634 @default.
• W2120239384 hasConcept C502942594 @default.

• next